MEDX vs. CNCR

Last updated Jun 5, 2026

MEDX (Horizon Kinetics Medical ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. MEDX is actively managed, while CNCR is passively managed. MEDX charges 0.85%/yr vs 0.79%/yr for CNCR.

Performance

MEDX vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Horizon Kinetics Medical ETF (MEDX) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

MEDX

• 1D: 3.04%
• 1M: 5.53%
• YTD: 3.90%
• 6M: 3.58%
• 1Y: 32.14%
• 3Y*: 6.55%
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

MEDX vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
MEDX Horizon Kinetics Medical ETF	-0.77%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

MEDX vs. CNCR - Sectors Allocation Comparison

Sectors	MEDX	CNCR
Healthcare	100.0%	96.6%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	3.3%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

MEDX vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDX

MEDX Risk / Return Rank: 55
MEDX Sharpe Ratio Rank: 53
MEDX Sortino Ratio Rank: 59
MEDX Omega Ratio Rank: 50
MEDX Calmar Ratio Rank: 63
MEDX Martin Ratio Rank: 51

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEDX vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Horizon Kinetics Medical ETF (MEDX) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MEDX	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	1.78	—	—
Sortino ratio: Return per unit of downside risk	2.77	—	—
Omega ratio: Gain probability vs. loss probability	1.31	—	—
Calmar ratio: Return relative to maximum drawdown	3.06	—	—
Martin ratio: Return relative to average drawdown	8.51	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	MEDX	CNCR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.78	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.32	—	—

Drawdowns

MEDX vs. CNCR - Drawdown Comparison

The maximum MEDX drawdown since its inception was -23.10%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for MEDX and CNCR.

Drawdown Indicators

	MEDX	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-23.10%	0.00%	-23.10%
Max Drawdown (1Y) Largest decline over 1 year	-10.54%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-23.10%	—	—
Current Drawdown Current decline from peak	-2.68%	0.00%	-2.68%
Average Drawdown Average peak-to-trough decline	-6.72%	0.00%	-6.72%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.79%	—	—

Volatility

Volatility by Period

	MEDX	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.68%	—	—
Volatility (6M) Calculated over the trailing 6-month period	13.41%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	18.12%	0.00%	+18.12%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.04%	0.00%	+17.04%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.04%	0.00%	+17.04%

MEDX vs. CNCR - Expense Ratio Comparison

MEDX has a 0.85% expense ratio, which is higher than CNCR's 0.79% expense ratio.

Dividends

MEDX vs. CNCR - Dividend Comparison

MEDX's dividend yield for the trailing twelve months is around 1.19%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%
MEDX Horizon Kinetics Medical ETF	1.19%	1.23%	1.92%	4.94%

Frequently Asked Questions

Which ETF is better, MEDX or CNCR?

On fees, CNCR is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, MEDX or CNCR?

CNCR is cheaper with a 0.79% expense ratio, compared with 0.85% for MEDX.

Which ETF pays a higher dividend yield, MEDX or CNCR?

MEDX has the higher dividend yield at 1.19%, compared with 0.00% for CNCR.

What is the main difference between MEDX and CNCR?

They also come from different issuers: Horizon and Exchange Traded Concepts. Their fees differ too: 0.85% for MEDX and 0.79% for CNCR.